Novartis and Bausch & Lomb's co-promote Retisert
This article was originally published in Clinica
Executive Summary
Bausch & Lomb (B&L) has enlisted the help of Novartis Ophthalmics, the eye business unit of pharmaceuticals giant Novartis, to promote its Retisert corticosteriod-releasing intravitreal implant in the US. Under the terms of the agreement, Novartis will supplement B&L's own sales effort by promoting the product to its network of retinal specialists. Rochester, New York-based B&L will retain responsibility for marketing and product strategy.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.